Products

Peerbridge Cor(TM) System
Peerbridge Health
Cardiology AI
The Peerbridge Cor™ System is an FDA-cleared, AI-enabled ambulatory ECG system that combines a wearable patch with a cloud-based platform to provide high-fidelity cardiac diagnostics and monitoring for up to 7 days. It offers advanced insights for conditions like arrhythmias, heart failure, and sleep apnea, aiming for earlier detection and improved patient outcomes.

See all 1 product →

About Peerbridge Health

Peerbridge Health is a digital healthcare company that is transforming remote cardiac care through an advanced AI-driven electrocardiogram (ECG) platform. The company develops and markets wearable multi-channel ECG patches, such as the Peerbridge Cor™, designed for continuous vital sign monitoring. This technology aims to provide high-fidelity heart rate and rhythm information, along with advanced ambulatory ECG capabilities, including recording fidelity and morphology. The goal is to enable fast, accurate, and affordable diagnoses, ultimately improving patients’ quality of life by bringing hospital-grade cardiac diagnostics into the home setting.

The Peerbridge platform leverages explainable AI and proprietary algorithms to analyze ECG data, expanding beyond traditional rhythm monitoring to detect and predict prevalent chronic illnesses such as heart failure, arrhythmias, and sleep apnea. Their solutions are designed to integrate seamlessly into existing clinical workflows, providing physicians with clear, decision-ready insights for earlier intervention and proactive management of cardiac conditions, without requiring specialized equipment or adding administrative burden. Recent trials have shown high accuracy in detecting heart failure directly from ECG inputs.

Peerbridge Health is committed to expanding access to life-saving cardiac diagnostics, particularly in rural and underserved areas, by offering cost-effective and easily deployable solutions. The company’s focus includes clinical validation through large-scale trials and the deployment of cloud-based reporting for clinicians.

Focus Areas

Cardiac monitoring Arrhythmia detection Heart failure detection Ejection fraction estimation Sleep apnea diagnosis Remote patient monitoring AI-driven diagnostics Wearable ECG technology Ambulatory ECG Cardiopulmonary diagnostics

Business Intelligence

Key InvestorsMedTech Innovator, HeartX Accelerator, HealthTech Arkansas Programs, Mayo Clinic Platform, HealthX Ventures, Mendota Venture Capital, Wingra Venture Capital
PartnershipsNorthwell Health, BetterNight, AT&T, HeartX program, Amendola
TechnologyAI-driven ECG platform, Wearable multi-channel electrocardiogram patch (Peerbridge Cor, Cor MDx), Cloud platform, IoT wearable, Einthoven Triangle design, AI-based signal processing and analytics, Cellular/LTE connectivity, Quantum-resonance signal processing, Software-as-a-Medical-Device (SaMD) platforms (CardioMIND, CardioQSync)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Cardiac Monitoring
Peerbridge Health offers the Peerbridge Cor and next-generation Cor MDx, which are 3-lead, 2-channel wireless continuous ECG wearable devices. They support full-spectrum monitoring, including 14-day Holter monitoring, mobile cardiac telemetry (MCT), advanced hemodynamic assessments, and acute care telemetry, with high-fidelity signal quality and real-time multi-lead streaming.
Arrhythmia Detection
The Peerbridge Cor device is capable of capturing 31 cardiac rhythms with superior recording fidelity, providing clear P-wave definition and precise QRS morphology for confident detection of changes.
Heart Failure Detection
Peerbridge Health's AI-enabled platform has demonstrated a 95.7% accuracy rate in feasibility trials for detecting heart failure (HFpEF and HFrEF) from ECG signals, aiming to enable earlier detection and intervention to reduce hospitalizations.
Ejection Fraction Estimation
The company is conducting a pivotal trial (EF-ACT) to determine Left Ventricular Ejection Fraction (LVEF) severity directly from its AI-enabled remote ECG wearable, enabling on-demand assessments of EF severity in both clinic and home settings.
Sleep Apnea Diagnosis
Peerbridge Cor has shown a statistically significant 91.2% predictive accuracy for determining the apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) directly from ECG waveforms, allowing for simultaneous diagnosis with cardiac rhythm disorders and structural heart disease.
Remote Patient Monitoring
The platform provides hospital-grade cardiac diagnostics and monitoring in home settings through its wearable ECG technology, supported by real-time data transmission via BLE and LTE connectivity, and a cloud analytics workflow with a clinician portal.
AI-Driven Diagnostics
Peerbridge Health leverages proprietary AI Software as a Medical Device (SaMD) platforms, CardioMIND and CardioQSync, which utilize advanced signal processing (originally developed for NASA and the U.S. Department of Defense) and physics-based biomarkers to identify over 30 cardiac and cardiopulmonary indications.
Wearable ECG Technology
The Peerbridge Cor and Cor MDx are compact, lightweight, patented 3-lead, 2-channel wireless ECG wearable devices designed for patient comfort and extended wear, featuring upgraded electronics, longer battery life, cellular connectivity, and wireless charging in the next-gen model.
Ambulatory ECG
The Peerbridge Cor is an FDA-cleared ambulatory ECG system that captures high-fidelity signals, enabling clinicians to detect meaningful changes sooner and supporting full-spectrum monitoring from Holter to mobile cardiac telemetry.
Cardiopulmonary Diagnostics
The COR-INSIGHT trial is validating the ability to provide non-invasive cardiovascular and cardiopulmonary measurements, including cardiac output and stroke volume, for over 30 different indications from a single wearable ECG study.
Physician Tip

Peerbridge Health stands out for physicians by offering hospital-grade cardiac and cardiopulmonary diagnostics directly from a single, low-cost wearable device, enabling earlier and more accurate detection of over 30 conditions, including heart failure, arrhythmias, ejection fraction severity, and sleep apnea. The platform is designed to integrate seamlessly into existing clinical workflows, providing decision-ready reports without adding administrative burden, and is reimbursable under standard ECG codes. This approach reduces the need for multiple in-hospital tests, lowers costs, and expands access to critical cardiac insights, particularly in underserved rural communities, ultimately leading to improved patient outcomes and reduced re-admissions. The use of explainable, physics-based AI ensures clinicians can understand the diagnostic conclusions, fostering trust and confidence in the technology.

Peerbridge Health's platform is built for seamless integration into existing clinical workflows, providing a clinic-friendly platform that produces consistent, decision-ready reports. They leverage strategic partnerships, such as with AT&T for the IoT backbone of their Cor MDx device, ensuring real-time data transmission and connectivity. The system includes a cloud analytics workflow and a clinician portal for efficient data reception, analysis, and reporting. Furthermore, the Cor device is reimbursable under standard ECG codes, supporting predictable margins and straightforward reconciliation for clinics.

Products by Peerbridge Health

1 product in the directory

Peerbridge Cor(TM) System
Peerbridge Health
Cardiology AI
The Peerbridge Cor™ System is an FDA-cleared, AI-enabled ambulatory ECG system that combines a wearable patch with a cloud-based platform to provide high-fidelity cardiac diagnostics and monitoring for up to 7 days. It offers advanced insights for conditions like arrhythmias, heart failure, and sleep apnea, aiming for earlier detection and improved patient outcomes.

Reviews & Opinions

No web reviews on file yet for Peerbridge Health. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Peerbridge Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Peerbridge Health →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Peerbridge Health offers the FDA-cleared Peerbridge Cor and the next-generation Cor MDx wearable ECG systems. These devices provide multi-channel, high-fidelity ambulatory ECG monitoring, capable of detecting 31 cardiac arrhythmias and serving as a Holter monitor replacement.
Peerbridge Health's AI-enabled platform, utilizing the Cor wearable, has demonstrated high accuracy in detecting heart failure directly from ECG signals. The company is also conducting pivotal trials (EF-ACT) to enable direct-from-ECG ejection fraction severity assessment, aiming to provide rapid, non-invasive, and cost-effective cardiac status insights.
Yes, the Peerbridge Cor wearable has shown significant predictive accuracy (91.2%) for diagnosing obstructive sleep apnea (OSA) directly from ECG waveforms. The Cor MDx device further expands capabilities to include non-invasive cardiopulmonary measurements like cardiac output and stroke volume, enabling over 30 indications through its COR-INSIGHT trial.
Peerbridge Health is centered on transforming remote healthcare with an advanced AI-driven ECG platform that brings hospital-grade diagnostics to the home setting. Their AI Software-as-a-Medical-Device (SaMD) platforms, CardioMIND and CardioQSync, analyze continuous ECG data to provide comprehensive cardiovascular, cardiopulmonary, and sleep-related insights.
The Peerbridge Cor system is FDA-cleared as an ambulatory ECG monitor and extended Holter monitor. The next-generation Cor MDx device is currently under FDA review for 510(k) clearance, with the company actively working with the FDA to secure SaMD labels for advanced diagnostics.
Peerbridge Health emphasizes a low-cost solution that aims to dramatically reduce diagnostic costs compared to traditional methods, with a physician-favorable billing model that keeps billing with the clinic. Their platform is designed to integrate seamlessly into existing workflows, providing consistent, decision-ready reports to minimize administrative burden.
Peerbridge Health recently closed a $7 million funding round to support the commercial rollout of its new products and has expanded its leadership. They have strategic partnerships with companies like AT&T for wireless connectivity, BetterNight for coordinated AFib and sleep apnea care, and are involved in programs like HeartX and trials with major health systems like Northwell Health.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.